Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-156680
Filing Date
2015-04-29
Accepted
2015-04-29 16:32:24
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d908068d10q.htm 10-Q 366528
2 EXHIBIT 31.1 d908068dex311.htm EX-31.1 9119
3 EXHIBIT 31.2 d908068dex312.htm EX-31.2 9140
4 EXHIBIT 32.1 d908068dex321.htm EX-32.1 4315
5 EXHIBIT 32.2 d908068dex322.htm EX-32.2 4422
  Complete submission text file 0001193125-15-156680.txt   3812177

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgdo-20150331.xml EX-101.INS 366198
7 XBRL TAXONOMY EXTENSION SCHEMA rgdo-20150331.xsd EX-101.SCH 44557
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgdo-20150331_cal.xml EX-101.CAL 45223
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgdo-20150331_def.xml EX-101.DEF 166983
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgdo-20150331_lab.xml EX-101.LAB 374672
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgdo-20150331_pre.xml EX-101.PRE 247980
Mailing Address 120 MOUNTAIN VIEW BOULEVARD BASKING RIDGE NJ 00000
Business Address 120 MOUNTAIN VIEW BOULEVARD BASKING RIDGE NJ 00000 908.580.2111
Regado Biosciences Inc (Filer) CIK: 0001311596 (see all company filings)

EIN.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35953 | Film No.: 15813241
SIC: 2834 Pharmaceutical Preparations